ADMA Biologics Inc (ADMA)
6.67
+0.15
(+2.30%)
USD |
NASDAQ |
May 01, 16:00
6.50
-0.17
(-2.55%)
After-Hours: 04:16
ADMA Biologics Cash from Operations (Quarterly): 17.60M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.60M |
| September 30, 2023 | 11.99M |
| June 30, 2023 | -6.059M |
| March 31, 2023 | -14.72M |
| December 31, 2022 | -7.379M |
| September 30, 2022 | -13.28M |
| June 30, 2022 | -12.83M |
| March 31, 2022 | -26.01M |
| December 31, 2021 | -33.47M |
| September 30, 2021 | -13.41M |
| June 30, 2021 | -32.26M |
| March 31, 2021 | -33.23M |
| December 31, 2020 | -32.22M |
| September 30, 2020 | -23.85M |
| June 30, 2020 | -21.28M |
| March 31, 2020 | -24.65M |
| December 31, 2019 | -19.65M |
| September 30, 2019 | -23.63M |
| June 30, 2019 | -18.62M |
| March 31, 2019 | -14.29M |
| December 31, 2018 | -18.79M |
| September 30, 2018 | -12.54M |
| June 30, 2018 | -14.91M |
| March 31, 2018 | -16.43M |
| December 31, 2017 | -13.36M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.739M |
| June 30, 2017 | -8.775M |
| March 31, 2017 | -5.398M |
| December 31, 2016 | -3.614M |
| September 30, 2016 | -4.683M |
| June 30, 2016 | -4.804M |
| March 31, 2016 | -5.168M |
| December 31, 2015 | -4.078M |
| September 30, 2015 | -2.673M |
| June 30, 2015 | -4.446M |
| March 31, 2015 | -4.221M |
| December 31, 2014 | -2.902M |
| September 30, 2014 | -2.466M |
| June 30, 2014 | -4.296M |
| March 31, 2014 | -5.040M |
| December 31, 2013 | -2.960M |
| September 30, 2013 | -2.226M |
| June 30, 2013 | -2.627M |
| March 31, 2013 | -3.075M |
| December 31, 2012 | -1.807M |
| September 30, 2012 | -2.101M |
| June 30, 2012 | -0.9969M |
| March 31, 2012 | -1.999M |
| December 31, 2011 | -0.0128M |
| September 30, 2011 | -0.0052M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-33.47M
Minimum
Dec 2021
17.60M
Maximum
Dec 2023
-17.21M
Average
-19.65M
Median
Dec 2019
Cash from Operations (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -3.732M |
| ANI Pharmaceuticals Inc | 44.74M |
| Ligand Pharmaceuticals Inc | 8.065M |
| Puma Biotechnology Inc | 10.46M |
| Bristol-Myers Squibb Co | 2.834B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.407M |
| Cash from Financing (Quarterly) | -38.99M |
| Free Cash Flow | 3.819M |
| Free Cash Flow Per Share (Quarterly) | 0.0716 |
| Free Cash Flow to Equity (Quarterly) | 27.62M |
| Free Cash Flow Yield | 0.26% |